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Innate lymphoid cells (ILCs) are a recently described group of innate immune cells that can regulate immunity,
inflammation, and tissue repair in multiple anatomical compartments, particularly the barrier surfaces of the
skin, airways, and intestine. Broad categories of ILCs have been defined based on transcription factor
expression and the ability to produce distinct patterns of effector molecules. Recent studies have revealed
that ILC populations can regulate commensal bacterial communities, contribute to resistance to helminth
and bacterial pathogens, promote inflammation, and orchestrate tissue repair and wound healing. This
reviewwill examine the phenotype and function ofmurine and human ILCs and discuss the critical roles these
innate immune cells play in health and disease.Introduction
Innate lymphoid cells (ILCs) represent a heterogeneous group
of hematopoietic cells of the innate immune system (Spits and
Cupedo, 2012; Spits and Di Santo, 2011). These cells appear
to differentiate from a common lymphoid progenitor, and they
comprise a small fraction of the total immune cell population
in lymphoid organs, at epithelial barrier surfaces, and in other
tissues (Spits and Cupedo, 2012; Spits and Di Santo, 2011).
While ILCs lack rearranged antigen-specific receptors, these
cells express many of the transcription factors and effector
molecules expressed by CD4+ T helper (Th) cell populations,
suggesting that ILCs may be an evolutionary precursor of
cells of the adaptive immune system (Spits and Cupedo,
2012; Spits and Di Santo, 2011). For example, the group 1
ILC population consists of natural killer (NK) cells and potentially
other ILCs that express the transcription factor T-bet, produce
interferon-g (IFN-g), and are associated with cell-mediated
immunity, similar to Th1 cells (Spits and Cupedo, 2012; Spits
and Di Santo, 2011). The group 2 ILCs are dependent on the
transcription factor RORa, express the transcription factor
GATA3, produce the Th2-associated cytokines interleukin-5
(IL-5) and IL-13, and promote antihelminth and allergic immune
responses, and thus are analogous to GATA3-expressing Th2
cells (Spits and Cupedo, 2012; Spits and Di Santo, 2011).
Finally, the group 3 ILC population is composed of fetal
lymphoid tissue inducer (LTi) cells that induce lymphoid organ-
ogenesis and recently described cells analogous to Th17
cells that are dependent on the transcription factor RORgt, pro-
duce IL-17A, IL-17F, and IL-22, and exert inflammatory and
protective effects on epithelial cells. This latter group includes
LTi-like cells, ILC17s, and NCR22s that express the NK cell
cytotoxicity receptor NKp46 (Spits and Cupedo, 2012; Spits
and Di Santo, 2011) (Figure 1). While the newly described cell
populations that fall within the group 2 and group 3 ILC subsets
share some features of LTi and NK cells, these ILCs are distinct
from classical LTi and NK cells in their developmental andfunctional requirements for specific cytokines during homeo-
stasis and inflammation (Spits and Cupedo, 2012; Spits and
Di Santo, 2011). As group 1 ILCs and classical LTi cells
have been discussed extensively elsewhere (Mebius, 2003;
Spits and Cupedo, 2012; Spits and Di Santo, 2011; van de
Pavert and Mebius, 2010), this review will focus on the develop-
ment and function of the GATA3-expressing group 2 ILCs and
the LTi-like, RORgt-dependent IL-17- and/or IL-22-expressing
group 3 ILCs.
Recent seminal studies have revealed critical roles for newly
described ILC populations. While the role of LTi cells in fetal
lymphoid organogenesis has been appreciated for many years
(Cupedo, 2011; Finke, 2009; Mebius, 2003; van de Pavert and
Mebius, 2010), recent studies have shown that group 3 ILC
populations function after fetal development by maintaining
tissue homeostasis at barrier surfaces, particularly the gut,
through interactions with commensal bacterial communities
(Spits and Cupedo, 2012; Spits and Di Santo, 2011). Other
studies have also revealed critical roles for group 2 ILCs in
mediating immunity to intestinal helminth parasites and bacte-
rial pathogens (Spits and Cupedo, 2012; Spits and Di Santo,
2011). Additional research has described proinflammatory
properties of ILCs associated with immune responses to infec-
tion and allergens, and in the context of inflammatory bowel
disease (IBD) (Spits and Cupedo, 2012; Spits and Di Santo,
2011). In addition to promoting immunity and inflammation in
some settings, recent analyses have highlighted a pivotal
role for both group 2 and group 3 ILCs in tissue repair and
immune homeostasis, either in the steady state or during the
resolution of inflammatory responses (Spits and Cupedo,
2012; Spits and Di Santo, 2011). This review will first describe
ILC development and heterogeneity and will then focus on
recent insights into how interactions between various ILC
subsets and commensal bacterial communities or patho-
genic microbes regulate homeostasis and inflammation in
the intestine.Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 445
Figure 1. Murine ILC Development and
Functional Heterogeneity
The ILC population can be broadly divided into
classical NK cells and potentially T-bet-expressing
ILCs (group 1 ILCs); GATA3-expressing ROR-
a-dependent ILCs that include NHCs, nuocytes
(nuo), Ih2 cells, lung ILCs, and potentially MPPtype2
cells (group 2 ILCs); and RORgt+ ILCs that include
LTi-like cells, ILC17s, and NCR22 cells (group 3
ILCs). All ILCs derive from an Id2-dependent
lymphoid precursor and respond to gc cytokines,
which play important roles in lymphoid cell devel-
opment and function. Group 1 ILCs produce
IFN-g. Group 2 ILCs express the IL-33R (T1/ST2)
and respond to IL-25 and IL-33 to produce IL-5,
IL-13, and Areg. RORgt+ group 3 ILCs partially
depend on AhR signaling for development and
function, and some express NK cell cytotoxicity
receptors such as NKp46. These cells express the
IL-23R, respond to IL-23, and can produce IL-17A,
IL-17F, and IL-22.
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Populations
Studies in murine model systems have revealed that the tran-
scription factor inhibitor of DNA-binding 2 (Id2) (Cherrier et al.,
2012; Eberl et al., 2004; Monticelli et al., 2011; Moro et al.,
2010; Satoh-Takayama et al., 2010; Yokota et al., 1999) and
signaling through the gc cytokine IL-7, which promotes hemato-
poietic cell development and proliferation (Moro et al., 2010;
Satoh-Takayama et al., 2010), are critical for the development
of all murine ILCs. However, group 2 and group 3 ILCs can be
distinguished in part by their differential requirements for various
factors during development. SomeRORgt– group 2 ILCs express
GATA3 (Liang et al., 2012; Moro et al., 2010; Price et al., 2010).
Others require RORa for development (Halim et al., 2012b;
Wong et al., 2012) and derive from a bone marrow-resident
lymphoid progenitor that is dependent upon the cytokine
receptor fms-like tyrosine kinase receptor 3, which is expressed446 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.by hematopoietic progenitors and sup-
ports lymphoid hematopoiesis (Yang
et al., 2011). In contrast, the RORgt+
group 3 ILCs are critically dependent on
RORgt during their development (Eberl
et al., 2004; Luci et al., 2009; Sanos
et al., 2009; Satoh-Takayama et al.,
2008). The aryl hydrocarbon receptor
(AhR), a helix-loop-helix family transcrip-
tion factor (Kiss et al., 2011; Lee et al.,
2012; Qiu et al., 2012), and members of
the Notch family of signaling molecules
(Cherrier et al., 2012; Lee et al., 2012;
Possot et al., 2011) also play important
roles in influencing the development of
group 3 ILCs (Figure 1).
The group 2 and group 3 ILCs can also
be distinguished by their phenotype and
functional capacity. Murine models of
infection or inflammation have been
instrumental in interrogating the pheno-
type and function of heterogeneous pop-ulations of ILCs. The group 2 ILCs include cell populations
termed natural helper cells (NHCs) (Moro et al., 2010), nuocytes
(Neill et al., 2010), and innate helper type 2 (Ih2) cells (Price et al.,
2010). While these cells were described independently, they
share many similar characteristics and may represent the
same cell type found in multiple tissue sites. Group 2 ILCs
respond to the epithelial cell-derived cytokines IL-25 and IL-33
through their expression of the IL-25 receptor (IL-17RB) and
the IL-33R (T1/ST2) and produce cytokines associated with
Th2 cells that induce allergic inflammation, including IL-5 and
IL-13, and the epidermal growth factor (EGF) family member
amphiregulin (Areg) (Monticelli et al., 2011; Moro et al., 2010;
Neill et al., 2010; Price et al., 2010).
Group 3 ILCs that express RORgt resemble LTi cells that
promote lymphoid organogenesis (Mebius, 2003), are found in
mucosal and lymphoid tissues, respond to the IL-12 family cyto-
kine IL-23 through expression of the IL-23R, and are capable of
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2009; Kinnebrew et al., 2012; Luci et al., 2009; Sanos et al.,
2009; Satoh-Takayama et al., 2008; Takatori et al., 2009). There
appears to be significant heterogeneity within the RORgt+ group
3 ILCs (Spits and Cupedo, 2012; Spits and Di Santo, 2011),
although, as with the group 2 ILCs, independently identified cell
types with slightly different phenotypes in different tissues may
represent the same cell type at various stages of differentiation
or activation. Some group 3 ILCs are predominantly IL-22 pro-
ducers and others primarily produce IL-17, while others can
produce IFN-g (although IFN-g-expressing ILCs may fall into the
group1 ILCsubset) (Buonocore et al., 2010;Cella et al., 2009;Kin-
nebrew et al., 2012; Satoh-Takayama et al., 2008; Takatori et al.,
2009; Vonarbourg et al., 2010). In addition, some RORgt+ ILCs,
termed NCR22 cells, also express the NK cell cytotoxicity
receptor NKp46, which may correlate with the ability to produce
IL-22, although the function of this NK cell receptor in RORgt+
ILCs is not known (Cella et al., 2009; Luci et al., 2009; Sanos
et al., 2009; Satoh-Takayama et al., 2008, 2009, 2010) (Figure 1).
While the requirement for RORgt, cytokine-producing
capacity, and effector function have been used to differentiate
group 2 and group 3 ILCs, there will likely be additional factors
that are critical for the development and function of one or
both populations. For instance, the identification of GATA3-
expressing group 2 ILCs suggests that this transcription factor
may play an important role in the development or activation of
this ILC population (Liang et al., 2012; Moro et al., 2010; Price
et al., 2010). Indeed, a recent study has shown that GATA3 is
required for IL-13 expression from one type of group 2 ILCs,
Ih2 cells (Liang et al., 2012), although the influence of GATA3
on development of group 2 ILCs has yet to be reported. More-
over, ILCs that do not fit into either category (for example, those
that do not express GATA3 or RORgt) may comprise a separate
population or multiple populations with currently unrecognized
functions. Alternatively, these cells may represent an immature
precursor pool from which mature RORgt– group 2 ILCs and
RORgt+ group 3 ILCs differentiate, although Diefenbach and
colleagues have proposed that loss, rather than gain, of RORgt
expression accompanies maturation of RORgt+ ILCs (Vonar-
bourg et al., 2010). Indeed, one distinct population of progen-
itor-like innate immune cells, designated multipotent progenitor
type 2 (MPPtype2) cells, responds to IL-25 and can differentiate
into mast cells, basophils, and macrophages that contribute to
the development of a Th2 cytokine response (Saenz et al.,
2010b). Further studies will be required to more precisely define
emerging ILC populations, their functions, and developmental
relationships.
Human ILC Populations
While ILC populations in humans are less well-defined than in
mice, recent significant advances have been made in the identi-
fication and characterization of human ILCs. For example, two
independent studies have described cells in human lung, intes-
tine, and nasal tissues that phenotypically and functionally
resemble murine group 2 ILCs (Mjo¨sberg et al., 2011; Monticelli
et al., 2011). Work byMonticelli et al. showed that a population of
cells that did not express markers for known immune cell line-
ages and did express IL-2Ra (CD25), IL-7Ra (CD127), and
IL-33R (ST2) could be identified in healthy human lung tissuesand in bronchiolar lavage fluid (BAL) (Monticelli et al., 2011).
Another study by Spits and colleagues described various popu-
lations of ILCs in the human fetal gut, including CD45intermediate
CD127+ RORgt+ group 3-like ILCs and CD45high CD127+ cells
that resembled murine group 2-like ILCs (Mjo¨sberg et al.,
2011). The CD45high CD127+ cells expressed very low levels of
RORgt but strongly expressed chemoattractant receptor-
homologous molecule expressed on Th2 lymphocytes (CRTH2)
(Mjo¨sberg et al., 2011), a marker associated with Th2 cells,
eosinophils, and basophils (Schuligoi et al., 2010). These
CD45high CD127+ CRTH2+ cells responded to IL-25 or IL-33
in vitro by producing IL-13, and similar group 2 ILC-like cells
could be found in multiple mucosal tissues in humans, including
fetal and adult gut and lung tissue (Mjo¨sberg et al., 2011). In addi-
tion, Delespesse and colleagues described a human CD34+
progenitor cell in the sputum of patients with asthma that ex-
pressed receptors for the epithelial cell-derived cytokines thymic
stromal lymphopoietin (TSLP) and IL-33, and could respond to
these cytokines to produce IL-5 and IL-13 (Allakhverdi et al.,
2009). These cells, similar to MPPtype2 cells in mice (Saenz
et al., 2010b), could promote extramedullary hematopoiesis
and Th2 cytokine production at tissue sites during allergic inflam-
mation (Allakhverdi et al., 2009) (Figure 2).
The human counterparts of themurine group 3 ILCs have been
more comprehensively described. Spits and colleagues identi-
fied human fetal LTi cells in the lymph nodes and spleen that
were negative for all lineage cell markers and expressed
CD127 and RORgt (Cupedo et al., 2009). Functionally, these
cells had the capacity to initiate some of the characteristic early
steps of lymphoid organogenesis through interactions with
mesenchymal cells that were mediated through the cytokines
lymphotoxin and tumor necrosis factor (TNF) (Cupedo et al.,
2009). Additionally, these cells could differentiate into mature
NK-like cells that retained CD127 surface expression and RORgt
expression and upregulated various other NK cell markers,
including the cytotoxicity receptors NKp46 and NKp44, and
both fetal LTi cells and their CD127+ NK cell progeny expressed
transcripts for IL17A and IL22 but not IFNg (Cupedo et al., 2009).
This study also reported the existence of LTi-like cells and
CD127+ NK cells in the postnatal tonsil that expressed RORgt
and could produce IL-17A and IL-22 after stimulation (Cupedo
et al., 2009). IL-22-producing RORgt+ ILCs have also been iden-
tified in healthy intestinal tissues from humans and nonhuman
primates (Sonnenberg et al., 2012). Moreover, RORgt+ LTi-like
cells have been described in noninflamed adult lymph nodes,
although compared to their fetal counterparts, these cells did
not express high levels of IL-17A or IL-22 (Hoorweg et al.,
2012). Colonna and colleagues described a similar population
in the tonsil, Peyer’s patches, and appendix as an NK-like cell
subset that expressed NKp44 and the chemokine receptor
CCR6 and produced IL-22 in response to IL-23 yet did not
appear to have cytotoxic capacity (Cella et al., 2009). Indeed,
a later study confirmed that the CD127+ RORgt+ LTi-like cells
present in the postnatal tonsil represented a distinct lineage
from that of classical NK cells (Crellin et al., 2010a). In addition,
group 3-like human ILC populations have been identified in in-
flamed tissues (Geremia et al., 2011). Powrie and colleagues
have described CD127+ ILCs that did not express the human
NK cell marker CD56 but produced IL-17A and IFN-g in theCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 447
Figure 2. Phenotypic and Functional Heterogeneity of Human ILCs
Innate cells that resemble murine group 2 and group 3 ILCs have been iden-
tified in various human tissues. Group 2 ILC-like cells that express the IL-2Ra
(CD25), the IL-7Ra (CD127), and the IL-33R (ST2) are found in adult lung and
BAL fluid. Similar cells that express CD127 and CRTH2 and respond to IL-25
and IL-33 to produce IL-13 have been identified in adult and fetal intestine and
lung, inflamed nasal polyps from rhinosinusitis patients, and adult peripheral
blood. Progenitor cells that express CD34, a marker of hematopoietic stem
cells, TSLPR, and ST2 are found in the sputum of asthma patients and respond
to TSLP and IL-33 to produce IL-5 and IL-13. Group 3 ILC-like cells that
express CD127 and RORgt, produce IL-17 and IL-22, and contribute to
lymphoid organogenesis are found in the fetal and adult lymph node and
spleen. Similar cells are found in the postnatal tonsil, adult lymph node, and
healthy and inflamed intestine. A group 3 ILC-like NK cell subset in the adult
tonsils, Peyer’s patches, and appendix expresses CD127, RORgt, the NK cell
marker NKp44, the IL-23R, and the chemokine receptor CCR6, and responds
to IL-23 to produce IL-22.
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2011). Collectively, these data established the existence of
group 3 ILCs in various human fetal and postnatal tissues
(Figure 2). However, future studies will be needed to fully eluci-
date the developmental requirements and functional profiles of
both group 2 and group 3 ILCs in healthy versus diseased human
tissues.
ILCs Promote Tissue Homeostasis in the Intestine
IL-22 and RORgt+ group 3 ILCs have been implicated in the
maintenance of intestinal barrier function and immune homeo-448 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.stasis (Spits and Cupedo, 2012; Spits and Di Santo, 2011). In
addition, these cells are critical in the formation andmaintenance
of lymphoid structures in the gut-associated lymphoid tissue
(GALT), including cryptopatches and isolated lymphoid follicles
(ILFs), which are thought to be sites of local T and B cell
responses (Spits and Cupedo, 2012; Spits and Di Santo,
2011). Although group 2 ILCs are present in the intestine of
germ-free (GF) mice that lack live commensal bacterial commu-
nities (Monticelli et al., 2011), the nature of their interactions with
these bacterial communities is currently unclear. To date, a role
for group 2 ILCs in maintaining intestinal homeostasis and medi-
ating GALT formation has not been described; therefore, this
section will focus on the role of IL-22-producing group 3 ILCs
that interact with commensal bacterial communities to mediate
intestinal tissue homeostasis (Figure 3).
Interactions between Commensal Bacterial
Communities and Group 3 ILCs
Multiple studies have addressed the nature of the interactions
between intestinal ILC populations and commensal bacterial
communities. In particular, whether ILCs require commensal
bacterial-derived signals for development has been an area of
intense interest. While NK cells and group 2-like ILCs develop
normally in the absence of commensal bacterial communities
(Ganal et al., 2012; Monticelli et al., 2011), studies to date have
not reached a consensus regarding the role of commensal bacte-
rial communities in the development of group 3 ILCs. Two initial
studies indicated that a population of NKp46+ group 3 ILCs in
the intestine was significantly reduced in GF mice (Sanos et al.,
2009; Satoh-Takayama et al., 2008), although one of these
studies also showed that the NKp46– LTi-like group 3 ILC popu-
lation was not affected (Sanos et al., 2009). Another study
showed that the population structure of the group 3 ILCs in the
intestine changes dramatically after microbial colonization that
occurs postnatally (Sawa et al., 2010). Specifically, Eberl and
colleagues have shown that group 3 ILC expression of the NK
cell-like marker NKp46 is regulated after birth, suggesting that
group 3 ILC populations change postnatally in response to or to
accommodate commensal bacterial-derived signals (Sawa
et al., 2010). However, the changes in population structure of
the group 3 ILCs observed following birth remained intact after
antibiotic treatment (Sawa et al., 2010), and subsequent studies
have shown that ILC-like populations persist in the intestine in
the absence of live commensal bacterial communities (Hamada
et al., 2002; Lee et al., 2012; Sanos et al., 2009; Sawa et al.,
2010, 2011; Sonnenberg et al., 2012). Moreover, the develop-
ment of RORgt+ group 3 ILC-like populations in the postnatal
intestine is unchanged in GF mice monoassociated with the
commensal segmented filamentous bacteria and in mice defi-
cient in various pathogen-associated molecular pattern recogni-
tion molecules, including Nod and MyD88 (Sawa et al., 2010).
Together, these data suggest that while the development of
intestinal group 3 ILCs does not depend on signals derived
from commensal bacterial communities, the phenotype, popu-
lation structure, and functional capacity of these cells in the
intestine change to accommodate physiologic alterations in the
intestinal environment following microbial colonization at birth
(Figure 3A). Further studies will be required to definitively charac-
terize the role of commensal bacterial communities in contrib-
uting to the fetal and postnatal development of group 3 ILCs.
Figure 3. ILC Interactions with Commensal
Bacterial Communities
(A) The population structure of RORgt+ group 3
ILCs changes dramatically after postnatal micro-
bial colonization, with a decrease in the size of the
LTi-like cell population and an increase in the size
of the NKp46+ ILC population occurring after birth.
(B) Colonization of mice by intestinal commensal
bacterial communities promotes IL-25 production
from intestinal epithelial cells. IL-25 acts on
dendritic cells (DCs) that subsequently limit IL-22
production from RORgt+ group 3 ILCs in the
lamina propria, thus decreasing production of IL-
22-dependent antimicrobial peptides. In the
GALT, IL-23-responsive IL-22-producing LTi-like
cells and IL-22-dependent antimicrobial peptides
are required to anatomically contain the lymph
node (LN)-resident commensal species Alcali-
genes xylosoxidans, which can cause systemic
inflammation following dissemination.
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effector cytokine production in ILC populations has also been
investigated. RORgt+ group 3 ILCs in mice and humans have
been shown to produce effector cytokines following exposure
to bacterial products, indicating that these cells may be tuned
to directly or indirectly respond to commensal bacterial-derived
signals (Crellin et al., 2010b; Kinnebrew et al., 2012; Takatori
et al., 2009). Specifically, several studies have examined how
signals derived from commensal bacterial communities influ-
ence the ability of ILC populations to produce IL-22 (Sanos
et al., 2009; Satoh-Takayama et al., 2008.; Sawa et al., 2011;
Sonnenberg et al., 2012; Vonarbourg et al., 2010), which plays
a role in maintaining intestinal barrier function and homeostasis
(Sonnenberg et al., 2011a). RORgt+ group 3 ILCs in the intestine
are the predominant source of IL-22, and RORgt-deficient mice
lack expression of IL-22 in the intestine (Sawa et al., 2011; Son-
nenberg et al., 2012). While one study indicated that IL-22-
producing ILC populations were not affected in mice with altered
commensal bacterial communities (Sonnenberg et al., 2012),
other studies have shown that IL-22-producing RORgt+
NKp46+ ILCs were reduced in GF mice (Sanos et al., 2009;
Satoh-Takayama et al., 2008; Vonarbourg et al., 2010), suggest-
ing that interactions with commensal bacterial communities may
be important for RORgt expression or IL-22 production from
innate cells. However, the presence of commensal bacterial
communities actually appears to repress IL-22 production from
RORgt+ group 3 ILCs in the intestine, as IL-22 expression was
enhanced in fetal mice and in adult GF or antibiotic-treated
mice that lack or have altered commensal bacterial communities
(Sawa et al., 2011). While the mechanisms of this repression are
not fully understood, commensal bacterial communities may
promote IL-25 production from epithelial cells, which in turn
downregulates IL-23 and IL-22 production (Sawa et al., 2011;
Zaph et al., 2008). These studies indicate that interactions
between commensal bacterial communities and ILCs may be
critical in modulating IL-22 production and the maintenance of
intestinal homeostasis (Figure 3B).Cell Host & Microbe 12,Other studies have investigated the
influence of RORgt+ group 3 ILCs on
intestinal inflammation. Damage to theintestinal epithelium in the dextran sodium sulfatemodel of intes-
tinal tissue damage and inflammation resulted in a significant
population expansion of RORgt+ ILCs and enhanced IL-22
expression in the intestine, indicating that intestinal inflammation
can override the suppressive effect of commensal bacterial
communities on IL-22 production from RORgt+ ILCs (Sawa
et al., 2011). Also, a recent study established a critical role
for LTi-like cell-derived IL-22 in preventing systemic inflamma-
tion caused by a loss of containment of the commensal
species Alcaligenes xylosoxidans (Sonnenberg et al., 2012)
(Figure 3B). Critically, Alcaligenes-specific immune responses
were detected systemically in patients with chronic inflammatory
diseases, including Crohn’s disease (Sonnenberg et al., 2012).
These two studies indicate that IL-22 derived fromRORgt+ group
3 ILCs may be key in resolving local inflammation in the intestine
and preventing systemic inflammation that results from dissem-
ination of commensal bacteria. However, while interactions with
commensal bacterial communities clearly influence the develop-
ment and function of group 3 ILCs in the intestine in the steady
state and in the context of inflammation, numerous questions
remain. In particular, the potential roles of antigen-presenting
cells (APCs) and adaptive immune cells in regulating ILC function
and the ability of ILCs to directly sense bacteria-derived prod-
ucts are areas requiring further investigation.
Group 3 ILCs Influence GALT Formation
In addition to their role in controlling lymphoid organogenesis in
the fetus (reviewed in Cupedo, 2011; Finke, 2009; Mebius, 2003;
van de Pavert andMebius, 2010), RORgt+ group 3 ILCs also play
a critical role in regulating formation of GALT, including crypto-
patches and ILFs, in the postnatal intestine (Spits and Cupedo,
2012; Spits and Di Santo, 2011). Cryptopatches were originally
described as small lymphoid aggregates in the small and large
intestine that developed after birth and were composed primarily
of CD127+ Thy1+ cells that expressed c-kit, the receptor for stem
cell factor and amarker of hematopoietic progenitors, but did not
express markers of T or B cells (Kanamori et al., 1996). These
lymphoid structures and the innate cells that composed themOctober 18, 2012 ª2012 Elsevier Inc. 449
Figure 4. ILCs Mediate Immune Response
to Pathogens in the Intestine
(A) During infection with the helminth parasite
N. brasiliensis, epithelial cells secrete IL-25 and
IL-33 that promote the accumulation of group 2
ILCs that express the IL-33R (T1/ST2) and
produce IL-5 and IL-13 to promote responses
from IL-4-producingmast cells and basophils. IL-4
derived from these sources and others supports
the development and maintenance of Th2 cells in
the draining lymph node (LN). IL-5 also recruits
eosinophils that produce IL-13. IL-13 from group 2
ILCs, mast cells, basophils, and eosinophils pro-
motes gut epithelial cell hyperplasia and mucin
secretion. In addition, MPPtype2 cells respond to
IL-25 from intestinal epithelial cells to induce ex-
tramedullary hematopoiesis and differentiation of
macrophages, mast cells, and basophils, which
support Th2 cytokine responses. Together, these
mechanisms lead to helminth expulsion.
(B) During infection with the enteric bacterial
pathogen C. rodentium, APCs in the intestine
produce IL-23. RORgt+ group 3 ILCs express the
IL-23R and respond to IL-23 by secreting IL-22,
which acts on epithelial cells to support produc-
tion of antimicrobial peptides that limit bacterial
replication.
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of commensal bacterial communities (Kanamori et al., 1996).
Subsequent studies showed that ILFs, which are distinct from
cryptopatches but may derive from them (Bouskra et al.,
2008), contain RORgt+ c-kit+ CD127+ LTi-like cells in addition
to B cells that are organized into germinal center-like structures
that robustly produce IgA (Tsuji et al., 2008). RORgt+ LTi-like
cells that resemble group 3 ILCs were important in the formation
and organization of cryptopatches and ILFs (Eberl and Littman,
2004) and maintenance of normal IgA levels, suggesting that
activities of group 3 ILCs can also support adaptive responses
in the intestine that help to maintain tissue homeostasis (Tsuji
et al., 2008). As is the case for cryptopatches, ILFs were present
in GF mice, although their composition was altered, and the
formation of these structures required signaling through CD127
(Hamada et al., 2002). The presence of intestinal IL-22-secreting
RORgt+ group 3 ILCs and the formation of cryptopatches and
ILFs have also been shown to be dependent on AhR (Kiss
et al., 2011; Lee et al., 2012), and partially dependent on Notch
signaling (Lee et al., 2012). Together, these studies establish
a critical role for RORgt+ ILCs in controlling the formation of
intestinal lymphoid structures.
ILCs as Innate Immune Effectors in the Intestine
that Mediate Resistance to Pathogens
In addition to the critical role of ILCs in maintaining intestinal
homeostasis through interactions with commensal bacterial
communities and supporting the formation and function of the
GALT, ILCs can act as potent innate immune effector cells that
promote resistance to intestinal pathogens (Spits and Cupedo,
2012; Spits and Di Santo, 2011). New tools and approaches
have revealed previously unrecognized roles for both group 2
and group 3 ILCs after infection with intestinal helminth and
bacterial pathogens (Spits and Cupedo, 2012; Spits and Di
Santo, 2011). The following section will describe the recent liter-
ature that has contributed to our understanding of the role of450 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.ILCs in promoting immune responses to pathogens that infect
the intestine (Figure 4).
Group 2 ILCs Promote Immunity to Intestinal Helminth
Infection
In 2010, four independent publications identified and character-
ized various innate cell populations (NHCs [Moro et al., 2010],
nuocytes [Neill et al., 2010], Ih2 cells [Price et al., 2010], and
MPPtype2 cells [Saenz et al., 2010b]) that responded to epithe-
lial-derived cytokines and were important in promoting immunity
to intestinal helminth parasites in mice. Initial studies had sug-
gested that innate cell populations might respond to the epithe-
lial cell-derived cytokines IL-25 and IL-33 (Schmitz et al., 2005;
Tulin et al., 2001). IL-25 induced production of Th2-associated
cytokines from an innate cell population that contributed to path-
ological changes in multiple organs, including the intestine (Fort
et al., 2001; Hurst et al., 2002). Subsequent studies indicated
that IL-25 signaling promoted the development of a nonB/nonT
c-kit+ FcεRI– innate immune cell population that was required
for resistance to the gastrointestinal nematode Nippostrongylus
brasiliensis (Fallon et al., 2006) and showed that IL-25 was
required for immunity to the helminth parasite Trichuris muris
(Owyang et al., 2006). IL-33-IL-33R (T1/ST2) interactions were
initially implicated in the promotion of Th2 cytokine responses
and associated allergic inflammation (Coyle et al., 1999; Lo¨hning
et al., 1998; Oshikawa et al., 2001, 2002; Saenz et al., 2010a;
Schmitz et al., 2005). Subsequent studies showed that IL-33
was important in the generation of adaptive immunity to
T. muris (Humphreys et al., 2008) and could also promote
T cell-independent pathology in the intestine and airways (Kondo
et al., 2008). Together, these studies set the stage for investiga-
tion into the roles of IL-25 and IL-33 in promoting innate cell
responses during helminth infection.
NHCs were the first group 2 ILC population described that re-
sponded to epithelial cell-derived cytokines and contributed to
Th2 cytokine-associated inflammation (Moro et al., 2010). In
elegant studies by Koyasu and colleagues, NHCs were
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other immune cell lineage markers and were present in the fat-
associated lymphoid tissue of mice (Moro et al., 2010). These
cells responded to IL-33, were elicited during N. brasiliensis
infection, and produced IL-5 and IL-13. Rag2//gc
/ mice,
which lack all adaptive immune cells and NHCs, were suscep-
tible to N. brasiliensis infection and exhibited delayed worm
clearance (Moro et al., 2010). Critically, adoptive transfer of
NHCs into Rag2//gc
/ mice was sufficient to promote IL-13
production and goblet cell hyperplasia in the intestine during
N. brasiliensis infection, which are both important in worm clear-
ance (Moro et al., 2010). In a subsequent study, IL-33-dependent
IL-5 and IL-13 responses were shown to be associated with the
population expansion of NHC-like cells and eosinophilia in the
lung of mice infected with the helminth Strongyloides venezue-
lensis (Yasuda et al., 2012) (Figure 4A).
Shortly after NHCs were described, other group 2 ILC popula-
tions that responded to IL-25 or IL-33 were identified and
characterized (Neill et al., 2010; Price et al., 2010; Saenz et al.,
2010b). A cell population termed ‘‘nuocytes’’ was first identified
by McKenzie and colleagues in the context of N. brasiliensis
infection using an IL-13 reporter mouse model (Neill et al.,
2010). A population of cells that did not express lineage markers
for known cell types, but did express the IL-25R (IL-17RB) and
the IL-33R (T1/ST2), were the predominant producers of IL-13
in the mesenteric lymph nodes after N. brasiliensis infection
(Neill et al., 2010). The transfer of IL-13-sufficient but not IL-
13-deficient nuocytes into susceptible Il17br/ mice could
promote worm expulsion, indicating that nuocyte-derived
IL-13 can mediate protective immunity to N. brasiliensis (Neill
et al., 2010). In addition, nuocytes were required for the develop-
ment of optimal Th2 responses, suggesting that these cells are
also important in promoting effective adaptive immune
responses (Neill et al., 2010). A follow-up study indicated that
the signaling adaptor molecule Act1 expressed by epithelial
cells plays an important role in promoting nuocyte responses
in this model (Kang et al., 2012). Another group 2 ILC population
referred to as Ih2 cells were identified by Locksley and
colleagues using another IL-13 reporter mouse model (Price
et al., 2010). In agreement with the findings of Neill et al., Ih2
cells that did not express markers of known immune cell line-
ages were the primary producers of IL-13 after exposure to
IL-25 or during N. brasiliensis infection (Price et al., 2010).
When Ih2 cells were transferred to Rag2//gc
/ mice in the
context of recombinant IL-25 treatment, these cells were able
to mediate worm expulsion (Price et al., 2010). An additional
study using this IL-13 reporter mouse has recently indicated
that GATA3 plays a critical role in the ability of Ih2 cells to mount
protective IL-13 responses during N. brasiliensis infection (Liang
et al., 2012) (Figure 4A).
Consistent with a role for IL-25 in promoting innate cell
responses during helminth infection, IL-25 has also been shown
to induce myelopoiesis that supports the generation of Th2 cyto-
kine responses during helminth infection (Saenz et al., 2010b).
Saenz et al. described a nonB/nonT c-kitintermediate innate
immune cell population that was elicited by IL-25-IL-25R
(IL-17RB) interactions and could differentiate into mast cells,
basophils, and macrophages (Saenz et al., 2010b). Based on
this multipotent capacity, these cells were designated MPPtype2cells (Saenz et al., 2010b). The progeny of MPPtype2 cells
promoted robust Th2 cytokine responses, and transfer of
MPPtype2 cells into normally susceptible IL-25-deficient mice
led to worm expulsion in the context of T. muris infection,
providing the first report that a multipotent innate cell population
could respond to epithelial cell-derived cytokines to mediate
immunity to a parasite (Saenz et al., 2010b). Therefore, IL-25
appears to elicit both ILC and myeloid progenitor responses,
although it is currently unclear whether or how these two cell
populations are related (Saenz et al., 2010a). Taken together,
the studies describing NHCs, nuocytes, Ih2 cells, and MPPtype2
cells indicate that various types of group 2 ILCs respond to
epithelial cell-derived cytokines and are pivotal players in the
immune response to helminth parasites (Figure 4A).
RORgt+ Group 3 ILCs Play a Critical Role in Immunity
to Gram-Negative Bacterial Infection
Initial studies in murine models of bacterial infection highlighted
the importance of IL-22 in promoting resistance to extracellular
bacterial pathogens at barrier surfaces. A study conducted by
Kolls and colleagues utilized a model of Klebsiella pneumoniae
infection to explore the role of IL-22 during bacterial infection
in the lung (Aujla et al., 2008). K. pneumoniae is an extracellular,
Gram-negative bacterial pathogen that provides a robust model
of infection at the pulmonary mucosal barrier (Ye et al., 2001). In
this model, IL-23-dependent IL-22 production was required for
antimicrobial responses in the lung epithelium, optimal bacterial
clearance, and resistance to infection (Aujla et al., 2008). The
authors concluded that T cells were the primary source of
IL-22, based on the lack of IL-22 production in Rag2//gc
/
mice (Aujla et al., 2008). However, mice that lack the gc,
a receptor subunit essential for the signaling of several cyto-
kines, are also deficient in ILCs; thus, retrospectively, these
data suggest a potential role for IL-22-producing gc-dependent
innate cells and highlight the critical importance of group 3
ILC-derived products in controlling pulmonary bacterial infec-
tions (Aujla et al., 2008). Indeed, a recent study has shown that
an innate IFN-g- and IL-17-producing cell population in the lungs
of mice subjected to a Bacillus Calmette-Gue´rin (BCG) vaccina-
tion protocol was associated with enhanced protection against
challenge with Mycobacterium tuberculosis (Pitt et al., 2012).
Further studies described an innate source of IL-22 in the
context of infection with Citrobacter rodentium (Cella et al.,
2009; Satoh-Takayama et al., 2008, 2009; Sonnenberg et al.,
2011b; Zheng et al., 2008), a Gram-negative attaching and
effacing enteric bacterium that naturally infects mice (Frankel
et al., 1996). IL-22 production was maintained in C. rodentium-
infectedRag2/mice, suggesting that innate cellswere a potent
source of IL-22 in this model (Zheng et al., 2008). A subsequent
study by Di Santo and colleagues showed that innate cells that
expressed NKp46 and RORgt were important IL-22 producers
during infection with C. rodentium, since Rag2//Il2rb/
mice, which lacked T and classical NK cells but retained
NKp46+ innate cells, mounted IL-22 responses and were resis-
tant to infection (Satoh-Takayama et al., 2008). Expression of
the marker NKp46 was later shown to be dispensable for IL-22
production and protection from C. rodentium infection (Satoh-
Takayama et al., 2009). In addition, NK cell-like innate cells in
the intestine were shown to robustly produce IL-22 during
C. rodentium infection, but whether these cells are the same orCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 451
Figure 5. Pro- and Anti-inflammatory
Activities of ILCs
(A) In response to various allergens and the influ-
enza A virus subtype H3N1, lung epithelial cells
produce IL-25 and IL-33 that promote IL-5 and
IL-13 production from lung-resident group 2 ILCs
that express the IL-33R (T1/ST2). IL-5 recruits
eosinophils to the tissue, and IL-13 induces
pathogenic epithelial cell proliferation and
contraction of smooth muscle tissue, causing
allergic airway inflammation and AHR. In the
intestine, in a model of H. hepaticus-induced
colitis, group 3 ILCs express the IL-23R and
respond to IL-23 to produce IL-17A and IFN-g that
together contribute to colitis.
(B) In contrast, during infection with influenza virus
A subtypeH1N1, IL-33 derived from epithelial cells
andmacrophages promotes Areg expression from
group 2 ILCs in the lung that express the IL-33R
(T1/ST2), which support reparative epithelial cell
proliferation. Additionally, in a model of OVA-
induced AHR, lung resident RORgt+ group 3 ILCs
produce IL-22 that limits the production of IL-5
and IL-13 that contributes to AHR.
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a recent study identified gut-resident CD4+ LTi-like cells as crit-
ical IL-22 producers that mediate resistance toC. rodentium and
orchestrate immune responses that upregulate antibacterial
effector mechanisms (Sonnenberg et al., 2011b), including
production of antimicrobial peptides (Liang et al., 2006). Notably,
this study showed that innate IL-22-producing LTi-like cells were
required for resistance to C. rodentium in lymphocyte-deficient
and lymphocyte-replete mice (Sonnenberg et al., 2011b). The
finding that group 3 ILCs are active in lymphocyte-replete mice
supports other studies that indicate that group 3 ILCs promote
adaptive immune responses. Group 3-like ILCs express the
costimulatory molecules CD30L and OX40L, allowing them to
interact with T cells (Kim et al., 2003, 2005). In addition, group
3-like ILCs contribute to the maintenance of CD4+ T cell memory
responses after immunization and infection with the intracellular
bacterium Listeria monocytogenes (Withers et al., 2009, 2012).
However, the potential role of group 3 ILCs in generating adap-
tive responses after Gram-negative bacterial infection in the
intestine remains unknown. Together, these data suggest that
IL-22-producing RORgt+ group 3 ILCs are critical cells in
promoting resistance to infection with Gram-negative extracel-
lular bacteria at barrier surfaces, including the lung and intestine
(Figure 4B).
ILCs and the Balance of Inflammation and Tissue Repair
In addition to their role as innate immune effectors during
immune responses to pathogens in the intestine and lung, ILCs
have also been shown to contribute to infection-induced inflam-
mation and other noninfectious inflammatory conditions,
including IBD and colitis (Spits and Cupedo, 2012; Spits and Di
Santo, 2011). Conversely, emerging studies suggest that ILCs
may have an important role in limiting inflammation and support-
ing tissue repair and wound healing mechanisms during the
resolution phase of immune responses against certain patho-
gens and insults (Spits and Cupedo, 2012; Spits and Di Santo,
2011). The following section will discuss the context-dependent
roles of ILCs in promoting inflammatory conditions and in
participating in the resolution of inflammation (Figure 5).452 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.ILCs Can Contribute to Inflammation at Barrier Surfaces
Group 2 ILCs have been shown to contribute to inflammation in
murine models of allergic inflammation in the lung and influenza-
induced airway hyperresponsiveness (AHR) (Barlow et al., 2012;
Bartemes et al., 2012; Chang et al., 2011; Halim et al., 2012a,
2012b; Kim et al., 2012; Wolterink et al., 2012). IL-33 and
IL-33R (T1/ST2) were initially shown to contribute to Th2 cell-
associated cytokine-mediated pathology and allergic airway
inflammation and AHR (Coyle et al., 1999; Schmitz et al., 2005)
in the absence of adaptive immune responses, suggesting that
innate cells respond to IL-33 to promote AHR (Kondo et al.,
2008). More-recent work has shown that group 2 RORa-de-
pendent or GATA3-expressing ILCs that produce IL-5 and
IL-13 in response to IL-25, IL-33, a fungal allergen, glycolipid
antigens, or the protease papain can promote AHR and/or
allergic airway inflammation (Barlow et al., 2012; Bartemes
et al., 2012; Halim et al., 2012a, 2012b; Kim et al., 2012; Wolter-
ink et al., 2012). In an influenza A virus infection-induced model
of AHR using the H3N1 influenza virus subtype, Umetsu and
colleagues reported that IL-13-producing group 2-like ILCs
that responded to IL-33 signals were sufficient to induce AHR
after viral infection (Chang et al., 2011) (Figure 5A). Critically,
these cells were also associated with allergic disease in human
patients, as the nasal polyps isolated from patients with chronic
rhinosinusitis were enriched for CD127+ CRTH2+ CD161+ ILCs
compared to uninflamed nasal tissues from nonallergic control
patients (Mjo¨sberg et al., 2011) (Figure 2). While the contribution
of group 2 ILCs to other allergic diseases, including those that
affect the skin, nasopharynx, and in particular the intestine,
have not yet been studied, the ability of these cells to produce
IL-5 and IL-13 suggest that they may play a role in the develop-
ment of wide array of allergic disorders.
The role of group 3 ILCs in intestinal inflammation has also
been investigated, and inflammatory roles have been described
for RORgt+ group 3 ILCs in the context of IBD (Buonocore et al.,
2010; Geremia et al., 2011). One study reported that IL-23
signaling in a murine model of Helicobacter hepaticus-mediated
colitis was associated with the accumulation of RORgt+ ILCs in
the colon that produced IL-17A and IFN-g and that depletion
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ure 5A). Of note, while the cells described above are capable
of producing IL-22, in the context of T cell-mediated colitis
IL-22 production has been reported to have an anti-inflammatory
effect (Zenewicz et al., 2008); thus, the relative contribution of
ILC-derived IL-22, IL-17A, and IFN-g in colitis remains to be
determined. As IL-17 and IL-22 can be either pathogenic or
protective in murine models of inflammation in the airway or
intestine (Ahern et al., 2008; Monteleone et al., 2012; Sonnen-
berg et al., 2010), the role of IL-17- or IL-22-producing group 3
ILCs is likely to be context dependent.
One recent report from Powrie and colleagues has highlighted
a potential role for LTi-like cells that resemble murine group 3
ILCs in a human disease state. A population of innate cells that
did not express markers of T cells isolated from the intestinal
lamina propria of patients with IBD expressed higher IL17A
and IL17F transcript levels than those isolated from the lamina
propria of noninflamed control patients, suggesting that an
innate source of IL-17 in the inflamed colon may contribute to
chronic inflammatory disease (Geremia et al., 2011). Further
examination indicated that patients with Crohn’s disease
showed an accumulation of CD127+ CD56– ILCs in the colon
and ileum compared to control patients, and that these cells
produced IL-17A and IFN-g (Geremia et al., 2011). While this
study did not directly assess whether this ILC population was
RORgt+, the surface phenotype and cytokine production profile
of these cells suggest that they express RORgt (Geremia et al.,
2011). Thus, these results indicate that RORgt+ ILCs may be
part of a complex immune cell infiltrate that contributes to the
development of chronic intestinal inflammation during IBD
(Geremia et al., 2011). However, additional studies will be
required to determine whether these cells play a role in the initi-
ation or maintenance of disease, and whether ILC interactions
with commensal or pathogenic bacteria influence intestinal
inflammation during IBD in patients.
ILCs Can Limit Inflammation and Mediate Tissue Repair
and Wound Healing
In addition to the established role of ILCs in promoting inflamma-
tion, ILCs can also limit inflammation and promote wound heal-
ing and tissue repair (Spits and Cupedo, 2012; Spits and Di
Santo, 2011). Recent reports have shown that group 2 ILCs
can participate in tissue repair in the lung. In a study byMonticelli
et al., expansion of group 2-like ILCs was observed in the lung of
mice infected with influenza A virus (H1N1 subtype), and deple-
tion of these cells in Rag1/ mice was associated with more
rapid host mortality due to decreased lung function and a loss
of lung epithelial barrier cell integrity (Monticelli et al., 2011).
Lung ILCs had a transcriptional profile enriched for genes that
promoted tissue repair and wound healing, including the gene
that encodes the EGF family member Areg (Monticelli et al.,
2011). In influenza A virus-infected mice depleted of lung ILCs,
treatment with recombinant Aregwas sufficient to rescue epithe-
lial cell barrier integrity and lung function, indicating that Areg
derived from lung ILCs is critical in tissue repair after acute injury
induced by influenza A virus infection (Monticelli et al., 2011)
(Figure 5B). These findings differ from those described by Chang
et al. showing that ILCs were pathogenic and contributed to
AHR after H3N1 influenza virus infection (Chang et al., 2011)
(Figure 5A). While the basis for the different findings in thesetwo studies remains unclear, the different subtypes of virus
used could play a role. Regardless, these findings further illus-
trate the context-dependent effects of ILC populations and the
need for further investigation of the tissue repair functions of
various types of ILCs at different barrier surfaces. Of note, tissue
repair functions have not yet been described for group 2 ILCs in
the intestine, although this is an area that requires further study,
as the tissue repair mechanisms ascribed to group 2 ILCs in the
lungmay also be critical in tissue repair and wound healing in the
intestine or other barrier surfaces.
In addition, group 3 and group 3-like ILCs have also been
shown to limit inflammation and contribute to tissue repair (Ku-
mar et al., 2012; Sawa et al., 2011; Scandella et al., 2008; Taube
et al., 2011). Scandella and colleagues reported that destruction
of normal lymphoid architecture and loss of the stromal cell
network occurs in the spleen in response to lymphocytic chorio-
meningitis virus (LCMV) infection (Scandella et al., 2008). Using
a bone marrow chimera approach in which wild-type mice
were reconstituted with Rorc/ cells to generate mice that
were deficient in RORgt+ ILCs, the authors showed that
LCMV-induced loss of stromal cell architecture in the spleen
was repaired by a population of RORgt+-dependent ILCs (Scan-
della et al., 2008). The ability of RORgt+ ILCs to aid in the regen-
eration of normal lymphoid architecture after LCMV infection is in
line with the requirement for LTi cells in the generation and orga-
nization of secondary lymphoid structure in the fetus (Mebius,
2003). However, LTi-like cells did not appear to participate in
the resolution of damage caused by other viral infections, indi-
cating that this may be a context-specific phenomenon (Scan-
della et al., 2008). Additional studies will be required to assess
whether RORgt+ group 3 ILCs participate in the reconstruction
of lymphoid structures after reorganization and damage that
occurs during other infections, particularly those that affect the
intestine and GALT.
Production of IL-22 by RORgt+ group 3 ILCs has also been
shown to limit inflammation in the lung. In a model of ovalbumin
(OVA)-induced airway inflammation, RORgt+ ILCs were a
predominant source of IL-22 in the inflamed lung (Taube et al.,
2011). Il22/mice had increased AHR symptoms, and adminis-
tration of recombinant IL-22 to Il22/ mice ameliorated AHR,
suggesting that ILC-derived IL-22 is anti-inflammatory during
allergic airway inflammation (Taube et al., 2011) (Figure 5B). A
new study has also described an IL-22-producing NK cell-like
population that mediates tracheal epithelial cell regeneration
and repair after influenza virus subtype H1N1 infection (Kumar
et al., 2012). Together, these reports suggest that ILCs can limit
inflammation and promote tissue repair in the lung. To date, the
role of group 3 ILCs in tissue repair after intestinal inflammation
has not been comprehensively investigated, although one study
has shown that IL-22-producing group 3 ILCs were protective in
a model of dextran sodium sulfate-induced colitis (Sawa et al.,
2011). As IL-22 can be tissue-protective (Sonnenberg et al.,
2011a), the capacity of the group 3 ILCs to produce this factor
suggests that these cells may contribute to the resolution of
inflammation in the intestine.
Summary and Future Perspectives
While recent studies have revealed considerable new infor-
mation regarding the development, phenotype, and role ofCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 453
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mation, and tissue repair, there is still much to be learned.
Whether various subpopulations of similar ILCs represent the
same cell type in various states of activation in heterogeneous
tissue sites remains to be clarified. In addition, many ques-
tions still remain regarding the development and functionality
of ILC subsets. In particular, the identity of the cell-intrinsic
and -extrinsic factors that govern ILC development, the loca-
tion of ILC differentiation, and the mechanisms that control
trafficking of ILC precursors and mature ILCs are not fully
understood. In addition, whether the RORgt-, RORa- and
GATA3-dependent group 2 ILCs and the RORgt+ group 3
ILCs represent fixed cell fates or there is plasticity in their
functional potential is unclear. While there is evidence for func-
tional plasticity in human ILCs (Crellin et al., 2010b; Spits and
Di Santo, 2011), whether this is true in mice, and whether this
functional plasticity is biologically relevant, remains to be
determined. For all ILC subsets, the ability to dynamically
regulate cytokine producing capacity and function in response
to the local cytokine environment may allow these cells to
more effectively participate in diverse inflammatory and
immune responses.
Other questions remain in terms of the functions of group 2
and group 3 ILCs in maintaining intestinal homeostasis and
during immune responses to pathogens and inflammation.
While recent studies have highlighted the role of ILCs in main-
taining intestinal homeostasis and barrier function, there is still
more to be learned regarding the complex interactions between
commensal bacterial communities, ILCs, and the intestinal
epithelium. Similarly, very little is known about the signaling
pathways that induce effector cytokine production from group
2 and group 3 ILCs during immune responses to pathogens,
inflammation, or tissue repair, and further study will be required
to assess the mechanisms that regulate the context-dependent
activities of ILCs. In addition to cytokine production, genome-
wide profiling studies have identified that both group 2 and
group 3 ILCs express a wide array of effector molecules, and
future studies will be required to interrogate the arsenal of ILC
effector functions and their capacity to regulate adaptive
immune responses. More broadly, how group 2 and group 3
ILCs participate in immune responses at various tissue sites,
including the intestine, against a wide array of pathogens and
during various inflammatory states has not been thoroughly
investigated. Perhaps most importantly, the phenotype and
function of ILCs in the context of human infectious disease
and in various inflammatory and autoimmune diseases has not
been reported. In addition to more-elaborate analysis of human
ILCs, new murine models and genetic approaches will allow
further definition of the phenotype, function, and regulation of
ILCs. These new insights will hopefully serve to inform the devel-
opment of new therapeutic approaches to manipulate ILC
responses in the context of multiple infectious and inflammatory
diseases.
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